123 related articles for article (PubMed ID: 38224471)
1. Urinary tissue factor (uTF), tissue factor pathway inhibitor (TFPI) and plasmin as novel biomarkers in early diagnosis of lupus nephritis.
Mustafa MH; Tony EAE; Elgendi SS; Abdelkader AS; Salah AA; Madkour RA
Egypt J Immunol; 2024 Jan; 31(1):143-154. PubMed ID: 38224471
[TBL] [Abstract][Full Text] [Related]
2. Urinary pro-thrombotic, anti-thrombotic, and fibrinolytic molecules as biomarkers of lupus nephritis.
Qin L; Stanley S; Ding H; Zhang T; Truong VTT; Celhar T; Fairhurst AM; Pedroza C; Petri M; Saxena R; Mohan C
Arthritis Res Ther; 2019 Jul; 21(1):176. PubMed ID: 31319876
[TBL] [Abstract][Full Text] [Related]
3. Urinary exosome tsRNAs as novel markers for diagnosis and prediction of lupus nephritis.
Chen S; Zhang X; Meng K; Sun Y; Shu R; Han Y; Feng Q; Li Z; Yang P; Liang J
Front Immunol; 2023; 14():1077645. PubMed ID: 36845141
[TBL] [Abstract][Full Text] [Related]
4. Utility of urinary transferrin and ceruloplasmin in patients with systemic lupus erythematosus for differentiating patients with lupus nephritis.
Urrego T; Ortiz-Reyes B; Vanegas-García AL; Muñoz CH; González LA; Vásquez G; Gómez-Puerta JA
Reumatol Clin (Engl Ed); 2020; 16(1):17-23. PubMed ID: 29530762
[TBL] [Abstract][Full Text] [Related]
5. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
[TBL] [Abstract][Full Text] [Related]
6. Validity of immunoglobulin-binding protein 1 as a biomarker for lupus nephritis.
Ebaid AM; Ezzeldin N; Abdelhady EI; Mohammed HA; Abdallah AL
Lupus; 2023 Jan; 32(1):101-110. PubMed ID: 36418233
[TBL] [Abstract][Full Text] [Related]
7. The role of urinary biomarker monocyte chemoattractant protein (MCP-1) in correlation with different histopathological classes of lupus nephritis in Egyptian patients.
El-Shinnawy H; Mahmoud O; Abdelmohsen W; Ahmed A; Khedr L
Egypt J Immunol; 2024 Jan; 31(1):116-123. PubMed ID: 38224276
[TBL] [Abstract][Full Text] [Related]
8. Urinary TNF-like weak inducer of apoptosis (TWEAK) as a biomarker of lupus nephritis.
Salem MN; Taha HA; Abd El-Fattah El-Feqi M; Eesa NN; Mohamed RA
Z Rheumatol; 2018 Feb; 77(1):71-77. PubMed ID: 27619369
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic test accuracy of novel biomarkers for lupus nephritis-An overview of systematic reviews.
Guimarães JAR; Furtado SDC; Lucas ACDS; Mori B; Barcellos JFM
PLoS One; 2022; 17(10):e0275016. PubMed ID: 36215243
[TBL] [Abstract][Full Text] [Related]
10. Prognostic and Diagnostic Values of Novel Serum and Urine Biomarkers in Lupus Nephritis: A Systematic Review.
Radin M; Miraglia P; Barinotti A; Fenoglio R; Roccatello D; Sciascia S
Am J Nephrol; 2021; 52(7):559-571. PubMed ID: 34515043
[TBL] [Abstract][Full Text] [Related]
11. The Role of urinary kidney injury molecule 1 (KIM-1) in monitoring the treatment response in Egyptian Lupus Nephritis Patients.
Khedr L; El-Shinnawy H; Hebah H; Rashwan H; Elsharabasy RM
Egypt J Immunol; 2024 Jan; 31(1):124-132. PubMed ID: 38224469
[TBL] [Abstract][Full Text] [Related]
12. Deep Phenotyping of Urinary Leukocytes by Mass Cytometry Reveals a Leukocyte Signature for Early and Non-Invasive Prediction of Response to Treatment in Active Lupus Nephritis.
Bertolo M; Baumgart S; Durek P; Peddinghaus A; Mei H; Rose T; Enghard P; Grützkau A
Front Immunol; 2020; 11():256. PubMed ID: 32265898
[TBL] [Abstract][Full Text] [Related]
13. Urinary interleukin 22 binding protein as a marker of lupus nephritis in Egyptian children with juvenile systemic lupus erythematosus.
Badr AMM; Farag Y; Abdelshafy M; Riad NM
Clin Rheumatol; 2018 Feb; 37(2):451-458. PubMed ID: 28887660
[TBL] [Abstract][Full Text] [Related]
14. Exploring urine:serum fractional excretion ratios as potential biomarkers for lupus nephritis.
Soliman SA; Stanley S; Vanarsa K; Ismail F; Mok CC; Mohan C
Front Immunol; 2022; 13():910993. PubMed ID: 36091001
[TBL] [Abstract][Full Text] [Related]
15. Serum uric acid as a predictor for nephritis in Egyptian patients with systemic lupus erythematosus.
Hafez EA; Hassan SAE; Teama MAM; Badr FM
Lupus; 2021 Mar; 30(3):378-384. PubMed ID: 33323012
[TBL] [Abstract][Full Text] [Related]
16. Urinary Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (uTWEAK) and Urinary Monocyte Chemo-attractant Protein-1 (uMCP-1): Promising Biomarkers of Lupus Nephritis Activity?
Elsaid DS; Abdel Noor RA; Shalaby KA; Haroun RA
Saudi J Kidney Dis Transpl; 2021; 32(1):19-29. PubMed ID: 34145111
[TBL] [Abstract][Full Text] [Related]
17. Urine Galectin-3 binding protein reflects nephritis activity in systemic lupus erythematosus.
Faustini F; Idborg H; Fuzzi E; Larsson A; Lie WR; Pötzsch S; Okitsu SL; Svenungsson E; Gunnarsson I
Lupus; 2023 Feb; 32(2):252-262. PubMed ID: 36508734
[TBL] [Abstract][Full Text] [Related]
18. Urine levels of HMGB1 in Systemic Lupus Erythematosus patients with and without renal manifestations.
Abdulahad DA; Westra J; Bijzet J; Dolff S; van Dijk MC; Limburg PC; Kallenberg CG; Bijl M
Arthritis Res Ther; 2012 Aug; 14(4):R184. PubMed ID: 22892043
[TBL] [Abstract][Full Text] [Related]
19. Serum uric acid as a sensitive concordant marker with lupus nephritis and new onset of renal damage: a prospective cohort study.
Elnady B; Almalki A; Abdel-Fattah MM; Desouky DE; Attar M
Clin Rheumatol; 2021 May; 40(5):1827-1834. PubMed ID: 33094396
[TBL] [Abstract][Full Text] [Related]
20. The association of urinary plasmin level with renal involvement and disease flare among systemic lupus erythematosus patients.
Fawzy R; Serag M; Soliman A; Elwia S; Mojahed S
Arch Rheumatol; 2022 Dec; 37(4):527-535. PubMed ID: 36879566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
